AdvaMed CEO Scott Whitaker Talks Mid-Terms, Device Tax and Innovative Programs for Smaller Companies

Scott Whitaker, the CEO of AdvaMed, has worked in DC for close to two decades. So naturally, we  asked him for his take on what the outcome of the midterm elections means for Medtech. Does it improve chances for the repeal of the Medical Device tax? We also talked about what AdvaMed is doing to entice smaller medtechs to join.